It tells your brain you're full, keeps blood sugar steady, and helps you metabolize fat more efficiently
The mechanisms responsible for these effects are not entirely clear, but the slowing of gastric emptying may be the key driver
Why visceral fat is dangerous Visceral fat in metabolic disease is typically insulin resistant , not insulin sensitive
Steven Batash, gastroenterologist and leading physician at the Batash Endoscopic Weight Loss Center, told Healthline
Long-Acting strategies for GLP-1 RAs, source: Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP, Drug Design, Development and Therapy, Oral Formulation The only available oral GLP-1RA is semaglutide (Rybelsus, Novo Nordisk)